Vaccine Developers Face Challenges in Scaling Up Manufacturing

A Government Accountability Office (GAO) review of COVID-19 vaccine development efforts found that vaccine producers are facing significant manufacturing hurdles as they scale up operations.
Source: Drug GMP Report